Ligand profile
ZINC1982
Virtual-screening candidate from ZINC.
Bound to: KP13_00107 — 4-hydroxybenzoate transporter
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1982- UniProt (similar protein)
Q4U2R8- Tanimoto
- 1.000
- Target protein
- KP13_00107
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 74.7
- −1 ≤ LogP ≤ 5 2.20
- MW ≤ 500 Da 285.4
- LogP ≤ 5 2.20
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 74.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1
InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)
DBABZHXKTCFAPX-UHFFFAOYSA-NDBABZHXKTCFAPX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL897
- Homolog
- Q4U2R8
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1982 →
- ZINC ZINC20 ZINC1982 →
- UniProt UniProt Q4U2R8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1982”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00107.
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).